1
Enquiry period
with 06.06.2023 17:01
to 16.06.2023 10:00
2
Bidding period
with 16.06.2023 10:00
to 07.07.2023 14:00
3
Auction
with 10.07.2023 15:00
to 10.07.2023 15:09
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 10 936 000 MDL
Period of clarifications: 6 Jun 2023, 17:01 - 16 Jun 2023, 10:00
Submission of proposals: 16 Jun 2023, 10:00 - 7 Jul 2023, 14:00

Supplier technical support:

(+373) 79999801

Advertising
Advertising

“Achiziționarea medicamentului Ocrelizumabum 30 mg/ml 10 ml , necesar IMSP Institutul Neurologie și Neurochirurgie „Diomid Gherman”, pentru anul 2023”

Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
6 Jun 2023, 16:43
Date modified
6 Jun 2023, 17:01
Achizitii.md ID
21081939
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Advertising
Documents of the procurement procedure
Model contract
Bidding Documents
Model contract
6.06.23 17:01
Propunerea tehnică
Technical Specifications
Propunerea tehnică
6.06.23 17:01
Anunt de participaree.signed
Bidding Documents
Anunt de participaree.signed
6.06.23 17:01
Documentatia standard.signed
Bidding Documents
Documentatia standard.signed
6.06.23 17:01
Scrisoare de garantie bancara_Model
Technical Specifications
Scrisoare de garantie bancara_Model
6.06.23 17:01
DUAE Model
Bidding Documents
DUAE Model
6.06.23 17:01
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
6.06.23 17:01
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
6.06.23 17:01
Propunerea financiară
Technical Specifications
Propunerea financiară
6.06.23 17:01
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
6.06.23 17:01
Only authorized platform users may ask questions during the clarification period.